PortfoliosLab logoPortfoliosLab logo
KURE vs. CNXT
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

KURE vs. CNXT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in KraneShares MSCI All China Health Care Index ETF (KURE) and VanEck Vectors ChinaAMC SME-ChiNext ETF (CNXT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, KURE achieves a -10.62% return, which is significantly lower than CNXT's 32.68% return.


KURE

1D
0.07%
1M
-12.32%
YTD
-10.62%
6M
-16.24%
1Y
-7.27%
3Y*
-6.01%
5Y*
-16.32%
10Y*

CNXT

1D
-0.62%
1M
9.11%
YTD
32.68%
6M
39.36%
1Y
114.61%
3Y*
26.75%
5Y*
3.96%
10Y*
6.57%
*Multi-year figures are annualized to reflect compound growth (CAGR)

KURE vs. CNXT - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
KURE
KraneShares MSCI All China Health Care Index ETF
-10.62%24.87%-17.83%-17.70%-25.43%-16.01%68.97%34.30%-30.07%
CNXT
VanEck Vectors ChinaAMC SME-ChiNext ETF
32.68%59.31%12.42%-21.47%-35.58%8.78%63.30%42.66%-38.75%

Correlation

The correlation between KURE and CNXT is 0.40, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.40

Correlation (3Y)
Calculated over the trailing 3-year period

0.63

Correlation (5Y)
Calculated over the trailing 5-year period

0.65

Correlation (All Time)
Calculated using the full available price history since Feb 2, 2018

0.68

Over the past year, the correlation between KURE and CNXT has dropped to 0.40 - well below their long-term average of 0.68, suggesting their price drivers have been diverging.

KURE vs. CNXT - Sectors Allocation Comparison


Sectors
KURE
CNXT

Healthcare

99.3%
7.0%

Consumer Defensive

0.7%
2.6%

Basic Materials

-

4.1%

Communication Services

-

2.5%

Consumer Cyclical

-

1.2%

Energy

-

-

Financial Services

-

5.6%

Industrials

-

33.2%

Real Estate

-

-

Technology

-

43.8%

Utilities

-

-

Healthcare

KURE
99.3%
CNXT
7.0%

Consumer Defensive

KURE
0.7%
CNXT
2.6%

Basic Materials

KURE

-

CNXT
4.1%

Communication Services

KURE

-

CNXT
2.5%

Consumer Cyclical

KURE

-

CNXT
1.2%

Energy

KURE

-

CNXT

-

Financial Services

KURE

-

CNXT
5.6%

Industrials

KURE

-

CNXT
33.2%

Real Estate

KURE

-

CNXT

-

Technology

KURE

-

CNXT
43.8%

Utilities

KURE

-

CNXT

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KURE vs. CNXT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KURE
KURE Risk / Return Rank: 77
Overall Rank
KURE Sharpe Ratio Rank: 66
Sharpe Ratio Rank
KURE Sortino Ratio Rank: 77
Sortino Ratio Rank
KURE Omega Ratio Rank: 77
Omega Ratio Rank
KURE Calmar Ratio Rank: 77
Calmar Ratio Rank
KURE Martin Ratio Rank: 77
Martin Ratio Rank

CNXT
CNXT Risk / Return Rank: 9393
Overall Rank
CNXT Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
CNXT Sortino Ratio Rank: 9292
Sortino Ratio Rank
CNXT Omega Ratio Rank: 8989
Omega Ratio Rank
CNXT Calmar Ratio Rank: 9696
Calmar Ratio Rank
CNXT Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KURE vs. CNXT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for KraneShares MSCI All China Health Care Index ETF (KURE) and VanEck Vectors ChinaAMC SME-ChiNext ETF (CNXT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


KURECNXTDifference
Sharpe ratioReturn per unit of total volatility

-4.03

Sortino ratioReturn per unit of downside risk

-4.61

Omega ratioGain probability vs. loss probability

0.97

1.55

-0.58

Calmar ratioReturn relative to maximum drawdown

-0.27

9.44

-9.71

Martin ratioReturn relative to average drawdown

-0.55

28.91

-29.46

KURE vs. CNXT - Sharpe Ratio Comparison

The current KURE Sharpe Ratio is -0.28, which is lower than the CNXT Sharpe Ratio of 3.75. The chart below compares the historical Sharpe Ratios of KURE and CNXT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


KURECNXTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.28

3.75

-4.03

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.51

0.11

-0.63

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.21

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.11

0.22

-0.33

Drawdowns

KURE vs. CNXT - Drawdown Comparison

The maximum KURE drawdown since its inception was -68.53%, roughly equal to the maximum CNXT drawdown of -68.98%. Use the drawdown chart below to compare losses from any high point for KURE and CNXT.


Loading charts...

Drawdown Indicators


KURECNXTDifference

Max Drawdown

Largest peak-to-trough decline

-68.53%

-68.98%

+0.45%

Max Drawdown (1Y)

Largest decline over 1 year

-27.53%

-12.21%

-15.32%

Max Drawdown (3Y)

Largest decline over 3 years

-34.05%

-48.60%

+14.55%

Max Drawdown (5Y)

Largest decline over 5 years

-67.94%

-61.21%

-6.73%

Max Drawdown (10Y)

Largest decline over 10 years

-63.30%

Current Drawdown

Current decline from peak

-61.08%

-2.76%

-58.32%

Average Drawdown

Average peak-to-trough decline

-38.08%

-42.93%

+4.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.24%

3.98%

+9.26%

Volatility

KURE vs. CNXT - Volatility Comparison

The current volatility for KraneShares MSCI All China Health Care Index ETF (KURE) is 7.22%, while VanEck Vectors ChinaAMC SME-ChiNext ETF (CNXT) has a volatility of 10.30%. This indicates that KURE experiences smaller price fluctuations and is considered to be less risky than CNXT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


KURECNXTDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.22%

10.30%

-3.08%

Volatility (6M)

Calculated over the trailing 6-month period

17.62%

19.99%

-2.37%

Volatility (1Y)

Calculated over the trailing 1-year period

26.44%

30.73%

-4.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.85%

35.26%

-3.41%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.38%

31.64%

+0.74%

KURE vs. CNXT - Expense Ratio Comparison

Both KURE and CNXT have an expense ratio of 0.65%.


Dividends

KURE vs. CNXT - Dividend Comparison

KURE's dividend yield for the trailing twelve months is around 4.69%, more than CNXT's 0.14% yield.


PositionTTM202520242023202220212020201920182017
CNXT
VanEck Vectors ChinaAMC SME-ChiNext ETF
0.14%0.18%0.15%0.00%0.00%9.22%0.01%0.45%0.00%0.19%
KURE
KraneShares MSCI All China Health Care Index ETF
4.69%4.19%1.29%0.65%0.05%14.12%0.00%0.25%0.21%0.00%

Frequently Asked Questions


KURE and CNXT have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CNXT has higher volatility (10.30%) compared to KURE (7.22%). In terms of maximum drawdown, KURE dropped -68.53% vs CNXT's -68.98%.

On 5-year performance, CNXT leads with 3.96% vs -16.32% for KURE. Both ETFs have the same 0.65% expense ratio. On volatility, KURE has been the lower-risk option at 7.22%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, CNXT has performed better with a 3.96% return vs -16.32%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

KURE and CNXT have the same expense ratio: 0.65% per year.

KURE has the higher dividend yield at 4.69%, compared with 0.14% for CNXT.

KURE tracks MSCI China All Shares Health Care 10/40 Index, while CNXT tracks SME-ChiNext 100 Index. They also come from different issuers: CICC and VanEck.

CNXT currently has the higher Sharpe Ratio (3.75 vs -0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for KURE and CNXT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer